E

Evelo Biosciences

83 employees

Evelo Biosciences is a biotechnology company that develops oral biologics for small intestinal axis with systemic therapeutic effects.

Basic info

biotechnology research

Biotechnology

Therapeutics

Health Care

Medical

2015

$50M

from 8 investors over 8 rounds

E

Evelo Biosciences raised $45M on December 16, 2022

Investors: Horizon Technology Finance

E

Evelo Biosciences raised $45M on July 25, 2019

Investors: K2 HealthVentures

E

Evelo Biosciences raised $48M on April 30, 2018

Investors: The Dementia Discovery Fund

E

Evelo Biosciences raised $50M on July 11, 2017

Investors: GV, Celgene, Flagship Ventures and Mayo Clinic Ventures

E

Evelo Biosciences raised $35M on November 4, 2015

Investors: Flagship Ventures